Compound Library

SARM / Classic SARM

GSK-2881078

Phase 2 clinical SARM studied for muscle wasting conditions. One of few SARMs with published Phase 2 human data. Showed anabolic effects but development discontinued.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dosePhase 2 doses: 0.5–2 mg/day
Half-life12 hours
Risk flagmoderate
Regulatory noteResearch-only flag

Side effects and watch-outs

  • HPTA suppression
  • Liver enzyme elevation in trials
  • HDL reduction
  • Hair loss (mild)
  • Development discontinued — compounded supply is not standardized